Biogen Idec gains MS drug approval
258793
The US government approved a drug Tuesday to treat multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.
189115
LOS ANGELES/NEW YORK  - The U.S. Food and Drug   Administration said on Wednesday it had approved Amgen Inc's   drug Vectibix for the treatment of advanced colon cancer.
152243
Shares in BiogenIdec (BIIB:Nasdaq - news - research) and Elan (ELN:NYSE - news - research)rose early Monday after the companies released what they described as &quot;compelling&quot; phase III test results for their multiple sclerosis drug Antegren.
81579
BOSTON  â Biogen Idec said on Wednesday its fourth-quarter profit rose 84 percent, topping expectations, driven by increased sales of its multiple sclerosis drugs Avonex and Tysabri.
18405
The Food and Drug Administration on Tuesday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
198678
Biogen Idec and Irish drugmaker Elan Corp. won government approval yesterday to sell a new multiple sclerosis drug, Tysabri. The drug, which some analysts predict will bring in $2 billion
667096
The biotech's new cancer candidate passes phase 1 trials.
304071
Biogen releases its third-quarter financial results.
736084
Biogen Idec Inc.  said on  Thursday that fourth-quarter earnings rose on higher sales of  its cancer and multiple sclerosis drugs.
321841
The Food and Drug Administration yesterday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
340456
A once-a-month drug for treating  multiple sclerosis that appears to cut relapses of the  autoimmune disorder was approved on Tuesday by the U.S. Food  and Drug Administration.
60402
Biogen Idec Inc. BIIB.O on Monday  reported a quarterly profit on sales of its multiple sclerosis  and cancer drugs versus a year-ago loss, but said costs will  rise in 2005, trimming earnings growth.
380448
Biotech company OSI Pharmaceuticals Inc. and biotech giant Genentech Inc. reported Friday that the Food and Drug Administration approved their Tarceva cancer treatment for patients with advanced non-small-cell
421575
Genentech and OSI Pharmaceuticals won federal approval yesterday to sell Tarceva, a pill to treat lung cancer. The approval by the Food and Drug Administration came well before the agency&#39;s
60593
Drug maker Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. said Friday that the Food and Drug Administration approved their antipsychotic drug Abilify for the treatment of acute bipolar mania.
563410
25/11/2004 - The first in a completely new class of drug for multiple sclerosis has been approved in the US, opening up a new avenue of treatment for sufferers of the debilitating diseases and potential blockbuster revenues for developers Elan and Biogen
594161
Genzyme announces positive study results with a recently acquired drug.